Point72 Europe (London) LLP Inari Medical, Inc. Transaction History

Point72 Europe (London) LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$37.11 - $50.69 $2.89 Million - $3.95 Million	-77,869 Reduced 19.12%	329,366 $15.9 Million
Q1 2024 May 15, 2024	BUY	$40.65 - $65.76 $3.05 Million - $4.93 Million	75,033 Added 22.59%	407,235 $19.5 Million
Q4 2023 Feb 14, 2024	BUY	$48.3 - $68.06 $7.68 Million - $10.8 Million	158,997 Added 91.8%	332,202 $21.6 Million
Q3 2023 Nov 14, 2023	BUY	$54.2 - $71.67 $9.39 Million - $12.4 Million	173,205 New	173,205 $11.3 Million

261

56.2M

90.4K

27.3K

Ticker NARI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,389,700
Market Cap $4.24B
Description
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...

Get notified when there are updates to the investment portfolio of Point72 Europe (London) LLP, based on Form 13F filings with the SEC.

Stay updated on Point72 Europe (London) LLP with notifications on news.